PROJECT

The SHIVA research program aims at developing personalized management of cerebral Small Vessel Desease (cSVD) : a new paradigm for preventing stroke, cognitive decline & dementia.

cSVD

Small vessels disease (SVD) is an age-related disease that results from alterations in the structure and/or function of the small arteries that supply blood to the brain. It is one of the main causes of stroke, memory loss and dementia in the elderly. The brain lesions that characterize it, and which are secondary to the damage of these small arteries, can be of several types: white matter hyperintensities (localized alteration of the white matter of the brain), brain lacunae (appearance of small cavities resulting from the destruction of the cerebral tissue), microbleeds (small bleedings occurring in the brain) or dilatation of the perivascular spaces (widening of the spaces surrounding the small blood vessels of the brain).


SVD is most often "covert" (cSVD), i.e. detectable only on a brain Magnetic Resonance Imaging.

Major role of cerebrovascular disease in pathophysiology of dementia :

A major target for healthy brain aging !

WORKPACKAGES

The project is organized around 6 Workpackages (WP) with strong interactions covering :

The proposed WP leaderships reflect a combination of high level methodological expertise, and strong clinical expertise and involvement to ensure optimal recruitment for the SHIVA cohort and rapid implementation of SHIVA results for improved patient care.

GOVERNANCE

The SHIVA project is supported by the University of Bordeaux and coordinated by Pr Stephanie Debette (coordinator) and Pr Thierry Couffinhal (co-coordinator).

The SHIVA's Governance ensure that the objectives, timeline and finances of the project are respected in the interest of the consortium, but also the scientific and ethical coherence of the project. The Governance is constituted by the Coordinating Institution, the General Assembly and the Executive Committee with the support of operational and consultative bodies.

Figure Governance SHIVA
The General Assembly is composed of scientific and administrative representatives of each of SHIVA's institutional and industrial partners. The GA acts as the ultimate decision-making body of the consortium with the mission of monitoring the research strategy and the progress of the project.
The SHIVA Project Coordination Team is, under the direction of the project coordinators, cored by a project manager ensuring the overall operational follow-up of the project, a translational project manager coordinating the clinical and regulatory components of the project, and an administrative and financial supervisor.

The team is specifically assigned to monitoring the project and is involved in the organisational, scientific and technical aspects in close collaboration with the partnership and development support provided by the Université de Bordeaux.
The Executive Committee is composed of coordinators and work package leaders. It acts as the main supervisory body for project implementation, reporting and accountability to the general assembly of partners.
The Scientific Advisory Board is composed of 6 external members, international scientific leaders with SHIVA’s complementary expertise. They have an advisory role and are responsible for assessing the overall scientific relevance of the project.
sab
The Ethics Advisory Board is appointed to evaluate the ethical and societal component of the project. It is composed by experts in ethics, clinicians and representatives of patient’s associations.
eab
The Business Liaison Committee's mission is the collaborative development of strategies for the valorisation of the project. It is led by a business manager and composed of representatives of SHIVA's academic and industrial partners in close relationship with SHIVA's Executive Committee.

PROJECT COORDINATION TEAM

The coordination Team, under the direction of the project coordinator, is composed of the project manager ensuring the operational follow-up of the whole project, a translational project manager coordinating the clinical and regulatory component of the project, and an administrative and financial manager.

The team is specifically assigned to monitoring the project and is involved in the organisational, scientific and technical aspects in close collaboration with the partnership and development support provided by the University of Bordeaux.

Stéphanie DEBETTE

SHIVA Coordinator, WP6 Leader, Neurologist


Thierry COUFFINHAL

SHIVA Co-coordinator, WP3 Leader, Cardiologist


Judith THOMAS CRUSELLS

Project manager


Morgane LACHAIZE

Clinical project manager


Lucile Rambelon

Administrative & financial manager


JOB OPPORTUNITIES

There is no open positions to join the RHU SHIVA. Don't hesitate to contact us for further information or to send us your spontaneous application. Thank you!